• share
• favorite_border

On Wednesday, October 21, Day Four of ITC will feature two Plenary Lectures: a morning presentation by Shigenobu Nagataki entitled “Radiation and the Thyroid: From Hiroshima/Nagasaki, Chernobyl to Fukushima,” with an introduction by Yoshiharu Murata; and an afternoon lecture by Samuel Refetoff, introduced by Roy Weiss, on Congenital Thyroid Disorders. A series of lively Discussions/Debates on Wednesday will focus on either clinical topics or basic/translational areas of research.

• share
• favorite_border

Two special lectures highlight the fifth day of programming at ITC, on Thursday, October 22. In the morning, Janete Maria Cerutti will deliver the Latin American Thyroid Association Prize Lecture, with an introduction by Rui Maciel. Delivering the European Thyroid Association Prize Lecture in the afternoon will be V. Krishna Chatterjee.

• share
• favorite_border

Renowned experts in thyroid function and biology, diagnosis and management of thyroid disease, and novel therapies for treating thyroid cancer will gather at the 15th International Thyroid Congress (ITC) to present, discuss, and debate the latest advances in thyroidology.

• share
• favorite_border

Featuring symposia, panel discussions and debates, and Plenary Lectures led by renowned endocrinology specialists, surgeons, and other healthcare professionals and experts in thyroidology from around the world, the 15th International Thyroid Congress (ITC) will take place October 18-23, 2015 at the Walt Disney World Swan and Dolphin Resort in Lake Buena Vista, Florida.

• share
• favorite_border

The effect of altered thyroid function on cardiac disease, depression and how dietary restrictions impact the thyroid are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida.

• share
• favorite_border

The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando (Lake Buena Vista), Florida.

• share
• favorite_border

The American Thyroid Association (ATA) will present the John B. Stanbury Thyroid Pathophysiology Medal to Sheue-yann Cheng, Ph.D. and the Distinguished Service Award to Peter A. Kopp, M.D. at the ATA's 85th Annual Meeting, being held together with the 15th International Thyroid Congress, October 18-23, 2015, in Lake Buena Vista, FL.

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce that first-year research grants have been awarded to three scientists who proposed novel projects to explore topics including the prevalence of mild thyroid stimulating hormone (TSH) in newborns, the cellular and metabolic basis of poor response to conventional treatment for hypothyroidism in some individuals, and whether or not the kidneys play an important role in iodine processing and thyroid function.

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce the awarding of first-year grants to support two young researchers selected from among a pool of applicants who proposed projects that will contribute novel insights and information with the potential to lead to new drug targets and therapeutic strategies to improve the treatment of thyroid cancer and patient outcomes.

• share
• favorite_border

The American Thyroid Association (ATA) is pleased to announce that grants have been awarded to support projects proposed by leading young researchers. Three of these projects involve the genetic analysis of thyroid tumors carrying the BRAFV600E mutation, which is associated with the development of some forms of thyroid cancer and increased risk for distant metastases, more advanced disease, and higher mortality. These studies aim to identify molecular markers that help clinicians assess patient risk and tailor treatments to improve patient outcomes and minimize side effects.

• share
• favorite_border

On May 25th the American Thyroid Association (ATA) (www.thyroid.org), in cooperation with international sister societies, the European Thyroid Association (www.eurothyroid.com), the Asia & Oceania Thyroid Association (www.aothyroid.org), and the Latin American Thyroid Society (www.lats.org) , will be making an extraordinary effort to do what it does year-round—focus attention on that small butterfly-shaped gland at the base of the neck that causes some 20 million Americans to experience “dis-ease” of one form or another.

• share
• favorite_border

The American Thyroid Association (ATA) has championed the effort to include a daily serving of iodine in multivitamin/mineral supplements intended for pregnant and breastfeeding women, and it applauds the new guidelines released by the U.S. Council for Responsible Nutrition (CRN) advising manufacturers to include 150 micrograms of iodine to these daily supplements.

• share
• favorite_border

The recipient of the 2014 Van Meter Award, established in 1930 by the American Thyroid Association for outstanding contributions by a young clinical scientist to research on the thyroid gland is Christine Spitzweg, M.D., Professor in Internal Medicine/Endocrinology, Chair of the Thyroid Center, Co-chair of the Center for Neuroendocrine Tumors, and Head of the research laboratory for Molecular Endocrinology at Ludwig-Maximilians-University Munich, Germany.

• share
• favorite_border

Robert C. Smallridge, M.D., will become the new ATA president, as Hossein Gharib, M.D., completes his term as president. Antonio Bianco, M.D., Ph.D., will become the new president-elect, and Victor J. Bernet, M.D. accepts the position of secretary/COO-elect. Joining the Board are three new directors: Julie Ann Sosa, M.D., Christine Spitzweg, M.D., and M. Regina Castro, M.D.

• share
• favorite_border

The American Thyroid Association will present the John B. Stanbury Thyroid Pathophysiology Medal to Valerie Anne Galton, Ph.D. and the 2014 Distinguished Service Award to Alan Farwell, M.D. at its 84th Annual Meeting, October 29 - November 2, 2014, in Coronado, California.

• share
• favorite_border

A unique mouse model of Graves' disease, an autoimmune disorder that causes hyperthyroidism, and new research findings that may help improve the treatment of Graves' disease will be highlighted.

• share
• favorite_border

The prevalence of papillary thyroid carcinoma (PTC), the most common type of thyroid cancer, is increasing rapidly. New research to determine the impact of radioactive iodine (RAI) therapy on survival in PTC, describing a novel blood test able to detect circulating BRAFV600E-positive tumor DNA, and identifying a long non-coding.

• share
• favorite_border

Novel therapeutic approaches to improve outcomes in thyroid cancer, for example using targeted delivery of cytotoxic drugs to tumor cells.

• share
• favorite_border

The recipients of Distinguished Lectureship Awards announced by the American Thyroid Association will each deliver an award lecture at the ATA's upcoming 84th Annual Meeting, October 29th - November 2nd, in Coronado, California.

• share
• favorite_border

The American Thyroid Association (ATA) is proud to announce a newly awarded research grant in collaboration with Bite Me Cancer and the valuable continuing partnership with ThyCa: Thyroid Cancer Survivors’ Association, Inc. (ThyCa).

• share
• favorite_border

The thyroid calculator for rapid calculation of: Calcitonin and Carcinoembryonic Antigen Doubling Time; Thyroid Nodule Volume change; Thyroid Cancer Staging. Calculation results are not preserved within the app, thus maintaining patient privacy and security.

• share
• favorite_border

CME program intended for endocrinologists, surgeons, and other clinicians will address the use of neck ultrasound to guide fine needle aspiration of thyroid nodules and the application of molecular markers and other topics necessary to guide decision-making in the treatment of thyroid nodules.

• share
• favorite_border

World Thyroid Day highlights five major goals to: o Increase awareness of thyroid health, o Promote understanding of advances made in treating thyroid diseases, o Emphasize the prevalence of thyroid diseases, o Focus on the urgent need for education and prevention programs, and o Expand awareness of new treatment modalities.

• share
• favorite_border

Van Meter Award for outstanding thyroid gland research recipient is Anne R. Cappola, M.D, Sc.M., an internationally recognized clinical investigator on the hormonal changes associated with aging.

• share
• favorite_border

International thyroid experts meet - high-level presentations on the latest research discoveries, clinical applications, therapeutic innovations, and collaboration to improve the care of individuals with thyroid disease and thyroid cancer.

• share
• favorite_border

Emerging data regarding vemurafenib, a BRAF-targeted inhibitor used with good effect for BRAF V600E mutation positive melanomas, are much anticipated.

• share
• favorite_border

A study designed to compare cure rates, postoperative pain, cosmetic satisfaction, and length of the procedure and of the hospital stay for patients with hyperparathyroidism who underwent BNE versus minimally invasive video-assisted (MIVAP) parathyroidectomy.

• share
• favorite_border

Review of cases spanning more than 12 years found that nearly a third of patients with DTC and neck metastases would not have had adequate operations if the surgeons had relied on pre-referral imaging studies and had not performed US themselves.

• share
• favorite_border

A novel drug target, and evidence of the strong anti-tumor effects of an inhibitor capable of blocking expression of the target are described.

• share
• favorite_border

Socioeconomic factors used to rank the different geographic regions that together are associated with higher use of radioactive iodine (RAI). These factors include significantly lower levels of income, education, and white collar employment.